Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
A
|
Daniel K Podolsky
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,220 Added 6.7% |
$303,740
$136.82 p/Share
|
Mar 17
2022 |
|
A
|
Sue H. Rataj
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,785 Added 7.12% |
$244,224
$136.82 p/Share
|
Mar 17
2022 |
|
A
|
George A Scangos
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,785 Added 8.83% |
$244,224
$136.82 p/Share
|
Mar 17
2022 |
|
A
|
Dow R Wilson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,785 Added 12.4% |
$244,224
$136.82 p/Share
|
Mar 17
2022 |
|
CDNS
|
Paul Cunningham
Sr. Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 5,214 Reduced 5.09% |
$742,995
$142.5 p/Share
|
Mar 17
2022 |
|
CDNS
|
Alinka Flaminia
Sr. VP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,153 Reduced 4.56% |
$449,302
$142.5 p/Share
|
Mar 17
2022 |
|
CDNS
|
Chin Chi Teng
Sr. Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 12,271 Reduced 7.36% |
$1,748,618
$142.5 p/Share
|
Mar 17
2022 |
|
CDNS
|
John M Wall
Sr. VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 13,030 Reduced 8.06% |
$1,856,775
$142.5 p/Share
|
Mar 17
2022 |
|
CDNS
|
Thomas P Beckley
Sr. Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 10,746 Reduced 4.77% |
$1,531,305
$142.5 p/Share
|
Mar 17
2022 |
|
CDNS
|
Anirudh Devgan
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 24,542 Reduced 9.85% |
$3,497,235
$142.5 p/Share
|
Mar 17
2022 |
|
CDNS
|
Aneel Zaman
Sr. Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 12,271 Reduced 10.15% |
$1,748,618
$142.5 p/Share
|
Mar 17
2022 |
|
CDNS
|
Lip Bu Tan |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 6.43% |
$7,598,500
$151.97 p/Share
|
Mar 17
2022 |
|
CDNS
|
Lip Bu Tan |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 6.04% |
$980,000
$19.6 p/Share
|
Mar 17
2022 |
|
CDNS
|
Lip Bu Tan |
SELL
Payment of exercise price or tax liability
|
Direct | 35,088 Reduced 4.82% |
$5,000,040
$142.5 p/Share
|
Mar 17
2022 |
|
AZO
|
K. Michelle Borninkhof
Senior Vice President & CIO |
BUY
Open market or private purchase
|
Direct | 259 Added 50.0% |
$503,786
$1945.12 p/Share
|
Mar 17
2022 |
|
MPC
|
Michael J Hennigan
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 42,482 Reduced 11.6% |
$3,246,474
$76.42 p/Share
|
Mar 17
2022 |
|
VRTX
|
Bastiano Sanna
EVP, Cell & Genetic Therapies |
SELL
Open market or private sale
|
Direct | 2,122 Reduced 4.2% |
$530,627
$250.06 p/Share
|
Mar 17
2022 |
|
VRTX
|
Charles F Wagner Jr
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,171 Reduced 6.42% |
$794,621
$250.59 p/Share
|
Mar 17
2022 |
|
VRTX
|
Ourania Tatsis
EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct | 2,833 Reduced 5.64% |
$710,148
$250.67 p/Share
|
Mar 17
2022 |
|
CCI
|
Catherine Piche
EVP & COO-Towers |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 15.17% |
$441,025
$176.41 p/Share
|
Mar 17
2022 |
|
CAT
|
Suzette M Long
CLO/General Counsel |
SELL
Open market or private sale
|
Direct | 40,356 Reduced 73.75% |
$8,878,320
$220.0 p/Share
|
Mar 17
2022 |
|
CAT
|
Suzette M Long
CLO/General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 36,540 Added 48.56% |
$4,859,089
$132.98 p/Share
|
Mar 17
2022 |
|
PRCT
|
Cpmg Inc |
SELL
Other acquisition or disposition
|
Indirect | 304,268 Reduced 2.71% |
-
|
Mar 17
2022 |
|
S
|
Daniel S Loeb
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 405,000 Reduced 3.94% |
$14,697,450
$36.29 p/Share
|
Mar 17
2022 |
|
S
|
Daniel S Loeb
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 3,000,000 Added 36.61% |
-
|
Mar 17
2022 |
|
CPNG
|
Greenoaks Capital Partners LLC
Director |
BUY
Open market or private purchase
|
Indirect | 200,000 Added 0.19% |
$3,770,000
$18.85 p/Share
|
Mar 17
2022 |
|
JOAN
|
Green Equity Investors Cf, L.P.
Director |
BUY
Exercise of conversion of derivative security
|
Indirect | 23,436 Added 50.0% |
-
|
Mar 17
2022 |
|
OSG
|
Cyrus Capital Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 25,000 Reduced 0.14% |
$54,000
$2.16 p/Share
|
Mar 17
2022 |
|
TFC
|
Charles A Patton |
BUY
Acquisition or disposition by will or laws
|
Indirect | 1,907 Added 50.0% |
-
|
Mar 17
2022 |
|
UNP
|
Jennifer L Hamann
EVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 2,668 Reduced 2.78% |
$704,752
$264.15 p/Share
|
Mar 17
2022 |
|
UNP
|
Jennifer L Hamann
EVP & CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 4,000 Added 4.0% |
$429,200
$107.3 p/Share
|
Mar 17
2022 |
|
JNJ
|
Thibaut Mongon
Exec VP, WW Chair, Cons Health |
SELL
Open market or private sale
|
Direct | 10,874 Reduced 14.56% |
$1,916,760
$176.27 p/Share
|
Mar 17
2022 |
|
JNJ
|
Thibaut Mongon
Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct | 30,785 Added 29.19% |
$3,108,361
$100.97 p/Share
|
Mar 17
2022 |
|
JNJ
|
Thibaut Mongon
Exec VP, WW Chair, Cons Health |
SELL
Open market or private sale
|
Direct | 23,681 Reduced 37.11% |
$4,174,013
$176.26 p/Share
|
Mar 17
2022 |
|
VNOM
|
Blackstone Holdings Iii L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.15% |
$593,400
$29.67 p/Share
|
Mar 17
2022 |
|
ZVIA
|
Jacqueline Hayes
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,607 Added 17.96% |
-
|
Mar 17
2022 |
|
ZVIA
|
Andrew Ruben |
BUY
Grant, award, or other acquisition
|
Direct | 5,607 Added 17.96% |
-
|
Mar 17
2022 |
|
ZVIA
|
Julie Garcia Ruehl |
BUY
Grant, award, or other acquisition
|
Direct | 5,607 Added 10.95% |
-
|
Mar 17
2022 |
|
ZVIA
|
Quincy B Troupe
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,607 Added 17.96% |
-
|
Mar 17
2022 |
|
ZVIA
|
Hany Mikhail
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,245 Added 19.87% |
-
|
Mar 17
2022 |
|
ZVIA
|
Lorna R. Simms
SVP, GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 18,140 Added 20.51% |
-
|
Mar 17
2022 |
|
ZVIA
|
Padraic L. Spence |
BUY
Grant, award, or other acquisition
|
Direct | 148,417 Added 5.41% |
-
|
Mar 17
2022 |
|
ZVIA
|
Amy Taylor
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 77,573 Added 30.4% |
-
|
Mar 17
2022 |
|
MRNA
|
Stephen Hoge
President |
BUY
Exercise of conversion of derivative security
|
Direct | 19,282 Added 1.17% |
$2,917,945
$151.33 p/Share
|
Mar 17
2022 |
|
RENT
|
Cara Schembri
Chief Legal & Admin. Officer |
SELL
Open market or private sale
|
Direct | 2,932 Reduced 1.41% |
$16,155
$5.51 p/Share
|
Mar 17
2022 |
|
RENT
|
Jennifer Hyman
Chair, CEO & President |
SELL
Open market or private sale
|
Direct | 18,774 Reduced 100.0% |
$103,445
$5.51 p/Share
|
Mar 17
2022 |
|
RENT
|
Jennifer Hyman
Chair, CEO & President |
BUY
Conversion of derivative security
|
Direct | 18,774 Added 50.0% |
-
|
Mar 17
2022 |
|
RENT
|
Anushka Salinas
President & COO |
SELL
Open market or private sale
|
Direct | 11,193 Reduced 1.89% |
$61,673
$5.51 p/Share
|
Mar 17
2022 |
|
RENT
|
Sarah K Tam
Chief Merchant Officer |
SELL
Open market or private sale
|
Direct | 4,468 Reduced 2.05% |
$24,619
$5.51 p/Share
|
Mar 17
2022 |
|
MED
|
Daniel R Chard
Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 878 Reduced 4.15% |
$158,497
$180.52 p/Share
|
Mar 17
2022 |